InMed Pharmaceuticals
INM • NASDAQ
InMed Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Eric A. Adams Chem., with a market cap of $2.4M.
Market Cap$2.4M
Employees13.0
CEOEric A. Adams Chem.
CountryCanada
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · In 3 weeksAfter Market Close · Q3 2026
Financials
InMed Pharmaceuticals FAQ
Common questions about InMed Pharmaceuticals
InMed Pharmaceuticals is scheduled to report earnings for Q3 2026 on May 11, 2026 after market close.
InMed Pharmaceuticals has approximately 13 employees.